{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# UMOD\n",
    "[autosomal dominant tubulointerstitial kidney disease-1 (ADTKD1)](https://omim.org/entry/162000) is caused by heterozygous mutation in the gene encoding uromodulin (UMOD)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using pyphetools version 0.9.97\n"
     ]
    }
   ],
   "source": [
    "from pyphetools.creation import TemplateImporter, Moi\n",
    "from pyphetools.visualization import IndividualTable, QcVisualizer\n",
    "from IPython.display import display, HTML\n",
    "import pyphetools\n",
    "print(f\"Using pyphetools version {pyphetools.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "template = \"input/UMOD_ADTKD1_individuals.xlsx\"\n",
    "created_by = \"0000-0002-0736-9199\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HPO version 2024-07-01\n",
      "Created encoders for 49 fields\n",
      "Importing OMIM:162002, Tubulointerstitial kidney disease, autosomal dominant, 2, HGNC:12559, UMOD,  NM_003361.4\n",
      "We output 207 GA4GH phenopackets to the directory phenopackets\n"
     ]
    }
   ],
   "source": [
    "timporter = TemplateImporter(template=template,  created_by=created_by)\n",
    "individual_list, cvalidator = timporter.import_phenopackets_from_template()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Cohort validation</h2>\n",
       "<p>Errors found with 16 of 207 phenopackets.</p>\n",
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>Error counts</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Level</th><th style=\"text-align: left;font-weight: bold;\">Error category</th><th style=\"text-align: left;font-weight: bold;\">Count</th></tr>\n",
       "<tr><td style=\"text-align: left;\">ERROR</td><td style=\"text-align: left;\">CONFLICT</td><td style=\"text-align: left;\">5</td></tr>\n",
       "<tr><td style=\"text-align: left;\">WARNING</td><td style=\"text-align: left;\">REDUNDANT</td><td style=\"text-align: left;\">11</td></tr>\n",
       "</table>\n",
       "<p>A total of 16 issues were fixed and no individual was removed from the cohort.</p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "qc = QcVisualizer(cohort_validator=cvalidator)\n",
    "display(HTML(qc.to_summary_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>207 phenopackets - PMID:15673476 (n=2); PMID:37487849 (n=1); PMID:18950917 (n=2); PMID:17245395 (n=10); PMID:14569098 (n=39); PMID:15575003 (n=2); PMID:14531790 (n=12); PMID:15844001 (n=2); PMID:20151160 (n=3); PMID:15983957 (n=17); PMID:21060763 (n=1); PMID:33574344 (n=11); PMID:36606057 (n=1); PMID:34904096 (n=1); PMID:33616882 (n=1); PMID:32847529 (n=4); PMID:32274456 (n=26); PMID:31068150 (n=2); PMID:29569962 (n=1); PMID:29513881 (n=11); PMID:27729211 (n=5); PMID:27764983 (n=8); PMID:25786455 (n=1); PMID:23988501 (n=9); PMID:28509303 (n=3); PMID:23826568 (n=2); PMID:23197950 (n=3); PMID:22034507 (n=27)</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Individual</th><th style=\"text-align: left;font-weight: bold;\">Disease</th><th style=\"text-align: left;font-weight: bold;\">Genotype</th><th style=\"text-align: left;font-weight: bold;\">Phenotypic features</th></tr>\n",
       "<tr><td style=\"text-align: left;\">proband (FEMALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.920A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P24Y</b>: Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P27Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 1 chronic kidney disease (HP:0012623)<br/><b>P44Y</b>: Renal corticomedullary cysts (HP:0000108)<br/><b>P49Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">son (MALE; P18Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.920A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Renal cyst (HP:0000107); Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient (MALE; P12Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.584G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P12Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 4 chronic kidney disease (HP:0012626); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Reduced renal corticomedullary differentiation (HP:0005565); Hyperechogenic kidneys (HP:0004719); Hyperuricemia (HP:0002149); Decreased urinary urate (HP:0011935); Metabolic acidosis (HP:0001942); Elevated circulating parathyroid hormone level (HP:0003165); Hyposthenuria (HP:0003158)<br/><b>P14Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Renal corticomedullary cysts (HP:0000108); excluded: IgA deposition in the glomerulus (HP:0000794); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">boy (MALE; P11Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.149G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P11Y</b>: Elevated circulating creatinine concentration (HP:0003259); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); Hyperechogenic kidneys (HP:0004719); Hyperuricemia (HP:0002149); Elevated circulating parathyroid hormone level (HP:0003165); Hyposthenuria (HP:0003158); Increased blood urea nitrogen (HP:0003138); Proteinuria (HP:0000093)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">father (MALE; P46Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.149G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P29Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F739 individual I-1 (MALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal hypoplasia (HP:0000089); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hypertension (HP:0000822); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F739 individual II-1 (MALE; P18Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F739individual II-2 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\">Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family K7 individual  I-1 (FEMALE; P9Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Reduced renal corticomedullary differentiation (HP:0005565); Hyperechogenic kidneys (HP:0004719); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Proteinuria (HP:0000093); Vesicoureteral reflux (HP:0000076); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822); excluded: Hyposthenuria (HP:0003158)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family K8 individual I-2 (FEMALE; P42Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\">Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family K8 individual II-2 (MALE; P9Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Hyperechogenic kidneys (HP:0004719); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Proteinuria (HP:0000093); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family K10 individual  I-1 (MALE; P6Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P6Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Reduced renal corticomedullary differentiation (HP:0005565); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Hypertension (HP:0000822); Hyposthenuria (HP:0003158); Proteinuria (HP:0000093); excluded: Thickened glomerular basement membrane (HP:0004722); excluded: Glomerular sclerosis (HP:0000096); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family K11 individual  I-1 (FEMALE; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Thickened glomerular basement membrane (HP:0004722); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); Hypertension (HP:0000822); Proteinuria (HP:0000093); excluded: Glomerular sclerosis (HP:0000096); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A214 I-1 (MALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Hypertension (HP:0000822); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hyposthenuria (HP:0003158); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A214 II-1 (MALE; P13Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P13Y</b>: Stage 2 chronic kidney disease (HP:0012624)<br/>Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Hypertension (HP:0000822); Hyposthenuria (HP:0003158); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Vesicoureteral reflux (HP:0000076)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 1 (UNKNOWN; P28Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P8Y</b>: Gout (HP:0001997)<br/><b>P28Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 2 (UNKNOWN; P36Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Gout (HP:0001997)<br/><b>P36Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 3 (UNKNOWN; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P19Y</b>: Gout (HP:0001997)<br/><b>P40Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 4 (UNKNOWN; P42Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P26Y</b>: Gout (HP:0001997)<br/><b>P42Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 5 (UNKNOWN; P54Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P32Y</b>: Gout (HP:0001997)<br/><b>P54Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 6 (UNKNOWN; P63Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P63Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 7 (UNKNOWN; P7Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P7Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 8 (UNKNOWN; P10Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P10Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 9 (UNKNOWN; P16Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P16Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 10 (UNKNOWN; P22Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P22Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual 11 (UNKNOWN; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.553C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 1 (UNKNOWN; P47Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Gout (HP:0001997)<br/><b>P47Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 2 (UNKNOWN; P23Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P23Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 3 (UNKNOWN; P26Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P26Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 4 (UNKNOWN; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P38Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 5 (UNKNOWN; P44Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P21Y</b>: Gout (HP:0001997)<br/><b>P44Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 6 (UNKNOWN; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P23Y</b>: Gout (HP:0001997)<br/><b>P45Y</b>: Chronic kidney disease (HP:0012622)<br/>Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual 7 (UNKNOWN; P54Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.665G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P28Y</b>: Gout (HP:0001997)<br/><b>P54Y</b>: Chronic kidney disease (HP:0012622)<br/>Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual 1 (UNKNOWN; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.563_661del (heterozygous)</td><td style=\"text-align: left;\"><b>P14Y</b>: Gout (HP:0001997)<br/><b>P38Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual 2 (UNKNOWN; P9Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.563_661del (heterozygous)</td><td style=\"text-align: left;\"><b>P9Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual 3 (UNKNOWN; P12Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.563_661del (heterozygous)</td><td style=\"text-align: left;\"><b>P12Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F4 individual 1 (UNKNOWN; P72Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.509G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P72Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F4 individual 2 (UNKNOWN; P73Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.509G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P73Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F4 individual 3 (UNKNOWN; P33Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.509G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P33Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F5 individual 1 (UNKNOWN; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.376T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P31Y</b>: Gout (HP:0001997)<br/><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F5 individual 2 (UNKNOWN; P31Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.376T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P20Y</b>: Gout (HP:0001997)<br/><b>P31Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F6 individual 1 (UNKNOWN; P64Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.334T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P30Y</b>: Gout (HP:0001997)<br/><b>P64Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F7 individual 1 (UNKNOWN; P57Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.610C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P38Y</b>: Gout (HP:0001997)<br/><b>P57Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F8 individual 1 (UNKNOWN; P59Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.176A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P59Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 1 (UNKNOWN; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P38Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal interstitial fibrosis (HP:0032948); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 2 (UNKNOWN; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 3 (UNKNOWN; P58Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P58Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 4 (UNKNOWN; P60Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P15Y</b>: Gout (HP:0001997)<br/><b>P60Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 5 (UNKNOWN; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 6 (UNKNOWN; P35Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P35Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 7 (UNKNOWN; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F9 individual 8 (UNKNOWN; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F10 individual 1 (UNKNOWN; P25Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.844T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P14Y</b>: Gout (HP:0001997)<br/><b>P25Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F11 individual 1 (UNKNOWN; P36Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.649T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P21Y</b>: Gout (HP:0001997)<br/><b>P36Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">index patient III.2 (FEMALE; P57Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1039T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P57Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Hyperuricemia (HP:0002149); Proteinuria (HP:0000093)<br/>Hypertension (HP:0000822); Renal hypoplasia (HP:0000089); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">daughter IV.2 (FEMALE; P33Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1039T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P33Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149); Proteinuria (HP:0000093)<br/>Hypertension (HP:0000822); Renal hypoplasia (HP:0000089); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F524 individual II-1 (MALE; P29Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P29Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Gout (HP:0001997); Hyperuricemia (HP:0002149); excluded: Thickened glomerular basement membrane (HP:0004722); excluded: Glomerular sclerosis (HP:0000096); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F524 individual II-3 (MALE; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); excluded: Renal interstitial fibrosis (HP:0032948); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F524 individual II-4 (MALE; P29Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 2 (OMIM:162001)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P29Y</b>: Chronic kidney disease (HP:0012622)<br/>Thickened glomerular basement membrane (HP:0004722); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Glomerular sclerosis (HP:0000096); excluded: Renal cyst (HP:0000107); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F739 individual I-1 (MALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 3 (OMIM:162002)</td><td style=\"text-align: left;\">NM_003361.4:c.743G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); excluded: Renal cyst (HP:0000107); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F739 individual II-1 (MALE; P18Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.743G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Chronic kidney disease (HP:0012622)<br/>Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F739 individual II-2 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.743G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P17Y</b>: Chronic kidney disease (HP:0012622)<br/>Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual III-5 (FEMALE; P60Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P60Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual III-10 (FEMALE; P37Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P37Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual III-11 (MALE; P56Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P56Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal cyst (HP:0000107); Renal hypoplasia (HP:0000089); Hypertension (HP:0000822); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual IV-1 (FEMALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P51Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual IV-2 (MALE; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Thickened glomerular basement membrane (HP:0004722); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Hypertension (HP:0000822); excluded: Glomerular sclerosis (HP:0000096); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F762 individual IV-3 (MALE; P42Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGGCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P42Y</b>: Chronic kidney disease (HP:0012622)<br/>Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal interstitial fibrosis (HP:0032948); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">child (MALE; P19Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.899G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P7Y6M</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 3 chronic kidney disease (HP:0012625); Glomerular sclerosis (HP:0000096); Hyperuricemia (HP:0002149); Increased blood urea nitrogen (HP:0003138)<br/><b>P19Y</b>: Gout (HP:0001997)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">mother (FEMALE; P55Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.899G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P25Y</b>: Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149)<br/><b>P55Y</b>: Stage 3 chronic kidney disease (HP:0012625)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1 (FEMALE; P14Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.891T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P6Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 3 chronic kidney disease (HP:0012625); Renal cyst (HP:0000107); Hyperuricemia (HP:0002149)<br/><b>P14Y</b>: Proteinuria (HP:0000093)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 2 (FEMALE; P5Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.891T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P5Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 2 chronic kidney disease (HP:0012624); Hyperuricemia (HP:0002149)<br/>Proteinuria (HP:0000093); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3 father (MALE; P39Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.891T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P17Y</b>: Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P39Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal hypoplasia (HP:0000089); excluded: Renal cyst (HP:0000107); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual I:1 (MALE; P70Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P70Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual II:1 (MALE; P67Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P42Y</b>: Renal cyst (HP:0000107)<br/><b>P67Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual II:10 (MALE; P65Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P50Y</b>: Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P51Y</b>: Renal cyst (HP:0000107)<br/><b>P64Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual III:1 (FEMALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P50Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual III:3 (FEMALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P51Y</b>: Hyperuricemia (HP:0002149)<br/>Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual III:4 (MALE; P53Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Gout (HP:0001997)<br/><b>P52Y</b>: Hyperuricemia (HP:0002149)<br/>Stage 1 chronic kidney disease (HP:0012623); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual III:5 (MALE; P32Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual III:6 (MALE; P32Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P27Y</b>: Hyperuricemia (HP:0002149)<br/>Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual IV:1 (MALE; P30Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P27Y</b>: Hyperuricemia (HP:0002149)<br/><b>P29Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F1 individual IV:3 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual II:1 (FEMALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P51Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual II:3 (FEMALE; P77Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P67Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F2 individual III:1 (MALE; P54Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.947A>C (heterozygous)</td><td style=\"text-align: left;\"><b>P15Y</b>: Hyperuricemia (HP:0002149)<br/><b>P31Y</b>: Gout (HP:0001997)<br/><b>P44Y</b>: Stage 1 chronic kidney disease (HP:0012623)<br/>Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual II:1 (FEMALE; P62Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.898T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P62Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997); excluded: Renal cyst (HP:0000107); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual II:2 (MALE; P61Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.898T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P55Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997); excluded: Renal cyst (HP:0000107); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual III:1 (FEMALE; P30Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.898T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P15Y</b>: Hyperuricemia (HP:0002149)<br/><b>P18Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F3 individual III:2 (FEMALE; P27Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.898T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P12Y</b>: Hyperuricemia (HP:0002149)<br/><b>P15Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">male index (MALE; P16Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1382C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P14Y</b>: Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P16Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Increased blood urea nitrogen (HP:0003138)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F1 (MALE; P24Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.104G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Gout (HP:0001997)<br/><b>P24Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F2 (FEMALE; P27Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1039T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P27Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F3 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.113A>T (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); excluded: Renal cyst (HP:0000107); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F4 (MALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.197T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P49Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Renal interstitial fibrosis (HP:0032948); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F5 (MALE; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.273del (heterozygous)</td><td style=\"text-align: left;\"><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F6 (MALE; P20Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.326T>A (heterozygous)</td><td style=\"text-align: left;\"><b>P20Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); excluded: Renal cyst (HP:0000107); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F7 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.334T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P41Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F8 (FEMALE; P26Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.707C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P26Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F9 (FEMALE; P26Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P26Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F10 (FEMALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.860G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Chronic kidney disease (HP:0012622)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">individual F11 (MALE; P25Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1153C>T (heterozygous)</td><td style=\"text-align: left;\"><b>P25Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case report (FEMALE; P15Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.280T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P13Y</b>: Renal corticomedullary cysts (HP:0000108); Elevated circulating creatinine concentration (HP:0003259); Stage 3 chronic kidney disease (HP:0012625); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149); Elevated circulating parathyroid hormone level (HP:0003165); Hypertension (HP:0000822); Hyposthenuria (HP:0003158); Increased blood urea nitrogen (HP:0003138); Proteinuria (HP:0000093)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient (MALE; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.554G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P25Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Gout (HP:0001997); Hyperuricemia (HP:0002149); Increased blood urea nitrogen (HP:0003138)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case report (MALE; P8Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.766T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P4Y</b>: Hyperuricemia (HP:0002149); Proteinuria (HP:0000093)<br/><b>P8Y</b>: Stage 2 chronic kidney disease (HP:0012624)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case presentation (MALE; P12Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.674C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P10Y</b>: Thickened glomerular basement membrane (HP:0004722); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Gout (HP:0001997); Hyperuricemia (HP:0002149)<br/><b>P12Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 111 (MALE; P58Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P58Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 112 (MALE; P55Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P55Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 113 (MALE; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 115 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P39Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hematuria (HP:0000790); Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 117 (FEMALE; P50Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P50Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 118 (MALE; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Chronic kidney disease (HP:0012622)<br/>Proteinuria (HP:0000093); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 1141 (MALE; P57Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P57Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCM individual 1151 (MALE; P36Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P36Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCO individual 122 (FEMALE; P47Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P47Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGCO individual 1111 (FEMALE; P42Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P42Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGGR individual 111 (MALE; P55Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P55Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hematuria (HP:0000790); Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGGR individual 114 (MALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P49Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGGR individual 151 (MALE; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P52Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGGR individual 152 (MALE; P50Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P50Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGGR individual 311 (MALE; P57Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P57Y</b>: Chronic kidney disease (HP:0012622)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGDC individual 111 (FEMALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGDC individual 112 (FEMALE; P46Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P46Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 1 (MALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 11 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P21Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 12 (MALE; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P38Y</b>: Chronic kidney disease (HP:0012622)<br/>Proteinuria (HP:0000093); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 21 (FEMALE; P68Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P68Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 22 (MALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P45Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGIT individual 234 (FEMALE; P35Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.605G>C (heterozygous)</td><td style=\"text-align: left;\"><b>P35Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJD individual 1 (FEMALE; P69Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.944G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P69Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJD individual 11 (MALE; P36Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.944G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P36Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJF individual 3 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJF individual 11 (FEMALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P51Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJF individual 13 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P40Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family FGJF individual 32 (FEMALE; P36Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.317G>T (heterozygous)</td><td style=\"text-align: left;\"><b>P36Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">index patient (MALE; P2Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1648G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P2Y</b>: Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Hematuria (HP:0000790)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">father (MALE; P29Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.1648G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P29Y</b>: Stage 5 chronic kidney disease (HP:0003774); Renal cyst (HP:0000107)<br/>Decreased urinary urate (HP:0011935); Hematuria (HP:0000790); Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">e index patient IV-1 (FEMALE; P16Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.667T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P14Y</b>: Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149); Hypertension (HP:0000822)<br/><b>P16Y</b>: Stage 2 chronic kidney disease (HP:0012624)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III:8 (FEMALE; P69Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P57Y</b>: Elevated circulating creatinine concentration (HP:0003259)<br/><b>P60Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/><b>P62Y</b>: Proteinuria (HP:0000093)<br/>Hyperechogenic kidneys (HP:0004719); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III:11 (FEMALE; P72Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P56Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III:9 (FEMALE; P63Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P63Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">IV:6 (FEMALE; P52Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Stage 3 chronic kidney disease (HP:0012625); Hyperechogenic kidneys (HP:0004719); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III:5 (MALE; P59Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Stage 2 chronic kidney disease (HP:0012624); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">IV:12 (MALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\"><b>P44Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Gout (HP:0001997); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">V:2 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997); excluded: Hyperuricemia (HP:0002149); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III:2 (FEMALE; P62Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">IV:10 (MALE; P48Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Elevated circulating creatinine concentration (HP:0003259); Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">IV:13 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">V:8 (MALE; P10Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.163G>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III.7 (MALE; P33Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.358T>G (heterozygous)</td><td style=\"text-align: left;\">Stage 2 chronic kidney disease (HP:0012624); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III.5 (FEMALE; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.358T>G (heterozygous)</td><td style=\"text-align: left;\">Stage 3 chronic kidney disease (HP:0012625); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III.6 (MALE; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.358T>G (heterozygous)</td><td style=\"text-align: left;\">Stage 3 chronic kidney disease (HP:0012625); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal hypoplasia (HP:0000089); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">III.1 (MALE; P47Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.358T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P47Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822); excluded: Renal hypoplasia (HP:0000089); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">II.1 (FEMALE; P65Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.358T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P65Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822); excluded: Renal hypoplasia (HP:0000089); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual TJ (MALE; P42Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P24Y</b>: Stage 5 chronic kidney disease (HP:0003774); Hyperuricemia (HP:0002149)<br/>Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual JD (FEMALE; P31Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P27Y</b>: Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149)<br/><b>P28Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Gout (HP:0001997); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual MdJ (FEMALE; P20Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P16Y</b>: Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Glomerular sclerosis (HP:0000096); excluded: Renal interstitial fibrosis (HP:0032948); excluded: Gout (HP:0001997); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual ŁJ (MALE; P25Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P21Y</b>: Elevated circulating creatinine concentration (HP:0003259); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual KJ (MALE; P3Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.229T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P3Y</b>: Hyperuricemia (HP:0002149)<br/>excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 Individual KM (FEMALE; P16Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.916T>A (heterozygous)</td><td style=\"text-align: left;\"><b>P16Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 3 chronic kidney disease (HP:0012625); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 Individual MZ (MALE; P37Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.916T>A (heterozygous)</td><td style=\"text-align: left;\"><b>P37Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 brother of MZ (MALE; P26Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.916T>A (heterozygous)</td><td style=\"text-align: left;\"><b>P26Y</b>: Stage 4 chronic kidney disease (HP:0012626)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient (FEMALE; P31Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.403T>G (heterozygous)</td><td style=\"text-align: left;\"><b>P31Y</b>: Stage 3 chronic kidney disease (HP:0012625); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149)<br/>excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F1 individual I-1 (FEMALE; P47Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.326T>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); Hypertension (HP:0000822); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F1 individual II-1 (MALE; P25Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.326T>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Hyperuricemia (HP:0002149); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F1 individual II-2 (MALE; P18Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.326T>A (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Tubulointerstitial nephritis (HP:0001970); Renal cyst (HP:0000107); Hyperuricemia (HP:0002149); excluded: Stage 1 chronic kidney disease (HP:0012623); excluded: Renal hypoplasia (HP:0000089); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F2 individual II-1 (MALE; P35Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P33Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Stage 1 chronic kidney disease (HP:0012623)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F2 individual II-2 (FEMALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P41Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>excluded: Stage 1 chronic kidney disease (HP:0012623)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F2 individual III-1 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.744C>G (heterozygous)</td><td style=\"text-align: left;\">Chronic kidney disease (HP:0012622); Renal cyst (HP:0000107); Hyperuricemia (HP:0002149); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 1 chronic kidney disease (HP:0012623); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal hypoplasia (HP:0000089); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F3 individual III-9 (FEMALE; P39Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.707C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P39Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Hyperuricemia (HP:0002149); excluded: Stage 1 chronic kidney disease (HP:0012623); excluded: Renal cyst (HP:0000107); excluded: Renal hypoplasia (HP:0000089); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F3 individual IV-8 (FEMALE; P24Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.707C>A (heterozygous)</td><td style=\"text-align: left;\"><b>P24Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Elevated circulating creatinine concentration (HP:0003259); Renal cyst (HP:0000107); Renal hypoplasia (HP:0000089); Hyperuricemia (HP:0002149); Hypertension (HP:0000822); excluded: Stage 1 chronic kidney disease (HP:0012623)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family F3 individual IV-9 (MALE; P20Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.707C>A (heterozygous)</td><td style=\"text-align: left;\">Stage 1 chronic kidney disease (HP:0012623); excluded: Elevated circulating creatinine concentration (HP:0003259); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Renal hypoplasia (HP:0000089); excluded: Hyperuricemia (HP:0002149); excluded: Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">index (FEMALE; P59Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.518C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P51Y</b>: Hypertension (HP:0000822); Proteinuria (HP:0000093)<br/><b>P55Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 2 chronic kidney disease (HP:0012624); Glomerular sclerosis (HP:0000096); Renal tubular atrophy (HP:0000092); Renal interstitial fibrosis (HP:0032948); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">sister (FEMALE; P61Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.518C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P61Y</b>: Elevated circulating creatinine concentration (HP:0003259); Stage 4 chronic kidney disease (HP:0012626); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Gout (HP:0001997)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">father (MALE; P84Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.518C>G (heterozygous)</td><td style=\"text-align: left;\"><b>P84Y</b>: Stage 4 chronic kidney disease (HP:0012626)<br/>Elevated circulating creatinine concentration (HP:0003259); Gout (HP:0001997); Hyperuricemia (HP:0002149); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">index (MALE; P16Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.187T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P16Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Gout (HP:0001997); Hyperuricemia (HP:0002149); Increased blood urea nitrogen (HP:0003138); Hematuria (HP:0000790); Proteinuria (HP:0000093)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Reduced renal corticomedullary differentiation (HP:0005565); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">father (MALE; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.187T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P34Y</b>: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">index (MALE; P18Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.688T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P18Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Gout (HP:0001997); Hyperuricemia (HP:0002149); Increased blood urea nitrogen (HP:0003138)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107); excluded: Hyperechogenic kidneys (HP:0004719); excluded: Renal hypoplasia (HP:0000089); excluded: Hypertension (HP:0000822); excluded: Hematuria (HP:0000790); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">brother (MALE; P21Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.688T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P21Y</b>: Elevated circulating creatinine concentration (HP:0003259); Chronic kidney disease (HP:0012622); Hyperuricemia (HP:0002149)<br/>excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal cyst (HP:0000107)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">father (MALE; P50Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.688T>C (heterozygous)</td><td style=\"text-align: left;\"><b>P50Y</b>: Stage 5 chronic kidney disease (HP:0003774); Renal cyst (HP:0000107)<br/>Hyperuricemia (HP:0002149)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AIII.4 (FEMALE; P54Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P54Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Polyuria (HP:0000103); Renal hypoplasia (HP:0000089); Hypertension (HP:0000822); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BII.4 (MALE; P48Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P48Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Stage 1 chronic kidney disease (HP:0012623); Stage 3 chronic kidney disease (HP:0012625); Renal hypoplasia (HP:0000089); Hypertension (HP:0000822); Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CIV.3 (MALE; P35Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Polyuria (HP:0000103); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal hypoplasia (HP:0000089); excluded: Hypertension (HP:0000822); excluded: Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DIII.3 (FEMALE; P46Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Stage 4 chronic kidney disease (HP:0012626); Hypertension (HP:0000822); excluded: Polyuria (HP:0000103); excluded: Stage 5 chronic kidney disease (HP:0003774); excluded: Renal hypoplasia (HP:0000089)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AII.1 (FEMALE; P50Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AII.2 (MALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Chronic kidney disease (HP:0012622); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AII.3 (FEMALE; P45Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AII.5 (FEMALE; P61Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P61Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Renal hypoplasia (HP:0000089); Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">AIV.8 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BI.1 (MALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BII.1 (MALE; P51Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Stage 4 chronic kidney disease (HP:0012626); Hypertension (HP:0000822); Proteinuria (HP:0000093); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BII.3 (FEMALE; P38Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P38Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BII.5 (FEMALE; P43Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P43Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">BII.6 (FEMALE; P41Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P41Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CII.1 (MALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Chronic kidney disease (HP:0012622); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CII.2 (FEMALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Stage 5 chronic kidney disease (HP:0003774); Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CIII.1 (MALE; P67Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P67Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Polyuria (HP:0000103); Stage 3 chronic kidney disease (HP:0012625); Gout (HP:0001997); Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CIII.2 (MALE; P65Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P65Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Stage 4 chronic kidney disease (HP:0012626); Hypertension (HP:0000822); Proteinuria (HP:0000093)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CIV.4 (MALE; P34Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Stage 3 chronic kidney disease (HP:0012625); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">CIV.5 (FEMALE; P30Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DII.3 (FEMALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DII.5 (FEMALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DII.7 (MALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DI.8 (FEMALE; P49Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DIII.1 (MALE; P53Y)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\"><b>P53Y</b>: Stage 5 chronic kidney disease (HP:0003774)<br/>Stage 4 chronic kidney disease (HP:0012626); Hypertension (HP:0000822)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DIII.5 (FEMALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Chronic kidney disease (HP:0012622); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">DIV.2 (FEMALE; n/a)</td><td style=\"text-align: left;\">Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)</td><td style=\"text-align: left;\">NM_003361.4:c.278_289delinsCCGCCTCCT (heterozygous)</td><td style=\"text-align: left;\">Chronic kidney disease (HP:0012622); Hypertension (HP:0000822); excluded: Stage 5 chronic kidney disease (HP:0003774)</td></tr>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table = IndividualTable(cvalidator.get_error_free_individual_list())\n",
    "display(HTML(table.to_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[pyphetools] Ingested 207 GA4GH phenopackets.\n",
      "[INFO] Extracted 183 from 207 phenopackets with OMIM:162000\n",
      "\n",
      "\tTubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000): n=183\n",
      "We found a total of 30 unique HPO terms\n",
      "Extracted disease: Tubulointerstitial kidney disease, autosomal dominant, 1 (OMIM:162000)\n",
      "Wrote HPOA disease file to OMIM-162000.tab\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#diseaseID</th>\n",
       "      <th>diseaseName</th>\n",
       "      <th>phenotypeID</th>\n",
       "      <th>phenotypeName</th>\n",
       "      <th>onsetID</th>\n",
       "      <th>onsetName</th>\n",
       "      <th>frequency</th>\n",
       "      <th>sex</th>\n",
       "      <th>negation</th>\n",
       "      <th>modifier</th>\n",
       "      <th>description</th>\n",
       "      <th>publication</th>\n",
       "      <th>evidence</th>\n",
       "      <th>biocuration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OMIM:162000</td>\n",
       "      <td>Tubulointerstitial kidney disease, autosomal d...</td>\n",
       "      <td>HP:0003774</td>\n",
       "      <td>Stage 5 chronic kidney disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>23/26</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:32274456</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-08-08]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>OMIM:162000</td>\n",
       "      <td>Tubulointerstitial kidney disease, autosomal d...</td>\n",
       "      <td>HP:0000093</td>\n",
       "      <td>Proteinuria</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>16/21</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:32274456</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-08-08]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>OMIM:162000</td>\n",
       "      <td>Tubulointerstitial kidney disease, autosomal d...</td>\n",
       "      <td>HP:0000790</td>\n",
       "      <td>Hematuria</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>2/20</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:32274456</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-08-08]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>OMIM:162000</td>\n",
       "      <td>Tubulointerstitial kidney disease, autosomal d...</td>\n",
       "      <td>HP:0012622</td>\n",
       "      <td>Chronic kidney disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>3/3</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:32274456</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-08-08]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>OMIM:162000</td>\n",
       "      <td>Tubulointerstitial kidney disease, autosomal d...</td>\n",
       "      <td>HP:0003774</td>\n",
       "      <td>Stage 5 chronic kidney disease</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>5/11</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:33574344</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-08-08]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    #diseaseID                                        diseaseName phenotypeID  \\\n",
       "0  OMIM:162000  Tubulointerstitial kidney disease, autosomal d...  HP:0003774   \n",
       "1  OMIM:162000  Tubulointerstitial kidney disease, autosomal d...  HP:0000093   \n",
       "2  OMIM:162000  Tubulointerstitial kidney disease, autosomal d...  HP:0000790   \n",
       "3  OMIM:162000  Tubulointerstitial kidney disease, autosomal d...  HP:0012622   \n",
       "4  OMIM:162000  Tubulointerstitial kidney disease, autosomal d...  HP:0003774   \n",
       "\n",
       "                    phenotypeName onsetID onsetName frequency sex negation  \\\n",
       "0  Stage 5 chronic kidney disease                       23/26                \n",
       "1                     Proteinuria                       16/21                \n",
       "2                       Hematuria                        2/20                \n",
       "3          Chronic kidney disease                         3/3                \n",
       "4  Stage 5 chronic kidney disease                        5/11                \n",
       "\n",
       "  modifier description    publication evidence  \\\n",
       "0                       PMID:32274456      PCS   \n",
       "1                       PMID:32274456      PCS   \n",
       "2                       PMID:32274456      PCS   \n",
       "3                       PMID:32274456      PCS   \n",
       "4                       PMID:33574344      PCS   \n",
       "\n",
       "                             biocuration  \n",
       "0  ORCID:0000-0002-0736-9199[2024-08-08]  \n",
       "1  ORCID:0000-0002-0736-9199[2024-08-08]  \n",
       "2  ORCID:0000-0002-0736-9199[2024-08-08]  \n",
       "3  ORCID:0000-0002-0736-9199[2024-08-08]  \n",
       "4  ORCID:0000-0002-0736-9199[2024-08-08]  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmid = \"PMID:15673476\"\n",
    "df = timporter.create_hpoa_from_phenopackets(pmid=pmid, mode_of_inheritance=Moi.AD, target=\"OMIM:162000\")\n",
    "df.head()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ps24venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
